Phytor comprises individuals from varying backgrounds, together creating our passionate and well-equipped team.
Mazal Korchia-Maor is co-founder of Phytor Ltd. Her 20 years of experience in management and marketing, as well as business administration, makes her the perfect choice to lead this company. Dr. Yehoshua Maor is the founder and senior consultant at Phytor Ltd. He has a PhD in medicinal chemistry, completed a postdoctoral fellowship at Harvard Institutes of Medicine, and has extensive experience working in the research of natural products. Dr. Raphael Seruya, lab manager and head of drug development R&D, is a graduate in pharmacy and biochemistry. He completed his PhD in microbiology and molecular genetics. Omri Duev has a masters degree in cell biology and immunology, as well as extensive knowledge of plant diversity and characteristics, making him a valuable member of our R&D research team. Dr. Izak Millman has a PhD in organic chemistry and over fifty years of experience working in chemistry R&D, including at big companies such as Teva, Sigma-Aldrich, and Merck. Hanna Hamou-Cohen has a masters degree in Organic Chemistry from École Nationale Supérieure des Industries Chimiques (ENSIC), Nancy, France and considerable experience in industrialization projects of targeted compounds. Ahuva Friedman has a B.Sc in Biomedical Science from North Park University in Chicago and previous experience working with biological assays from the National Institutes of Health, Bethesda.
Our company’s motto is, “Inspired by nature.” We specialize in providing naturally derived solutions and product development for a variety of biological systems, specifically the fields of oncology and neuro-degenerative diseases.
Our lab specializes in biologically led assays and the synthesis of novel chemical entities. Using these methods we have created a molecule library using derivatives from plant isolated molecules. There are several molecules within our library that are candidates for drug development against a variety of cancers and to be used for the early detection of neuro-degenerative diseases.